Chronic kidney disease, stage 3. Chronic kidney disease, stage 3
Conditions
Interventions
Intervention 1: Intervention group 1 will receive one capsule, containing 350 mg of almonds twice a day. The duration of treatment is 2 weeks.The drug is made in faculty of pharmacy, Shahid Beheshti U
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with chronic kidney disease stage 3 Range 18 to 65 years Patient consent
Exclusion criteria
Exclusion criteria: Clinically unstable Malignancy Heart Failure Previous diagnosis of primary hyperoxaluria History of calcium oxalate kidney stone Known allergy to almond Liver failure Pregnancy Inability to communicate Polycystic kidney disease Acute infectious disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glomerular filtration rate. Timepoint: Before the intervention, after the intervention. Method of measurement: Modification of Diet in Renal Disease (MDRD) formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum creatinine. Timepoint: Before the intervention, after the intervention. Method of measurement: Laboratory blood test.;Blood Urea Nitrogen. Timepoint: Before the intervention, after the intervention. Method of measurement: Laboratory blood test.;Blood pressure. Timepoint: Before the intervention, after the intervention. Method of measurement: Sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSedighe Meghdadi
Mazandaran University of Medical Sciences
Outcome results
None listed